Interleukin-1 and neuronal injury

被引:803
作者
Allan, SM
Tyrrell, PJ
Rothwell, NJ
机构
[1] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[2] Hope Hosp, Div Neurosci & Med, Salford M6 8HD, Lancs, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/nri1664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-1 is a pro-inflammatory cytokine that has numerous biological effects, including activation of many inflammatory processes ( through activation of T cells, for example), induction of expression of acute-phase proteins, an important function in neuroimmune responses and direct effects on the brain itself. There is now extensive evidence to support the direct involvement of interleukin-1 in the neuronal injury that occurs in both acute and chronic neurodegenerative disorders. This article discusses the key evidence of a role for interleukin-1 in acute neurodegeneration - for example, stroke and brain trauma - and provides a rationale for targeting the interleukin-1 system as a therapeutic strategy.
引用
收藏
页码:629 / 640
页数:12
相关论文
共 114 条
  • [1] Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
    Albers, GW
    Bogousslavsky, J
    Bozik, MA
    Brass, LM
    Broderick, JP
    Fisher, M
    Goldstein, LB
    Salazar-Grueso, E
    Akitsuki, S
    Aranko, K
    Ashwood, T
    Atkinson, RP
    Bell, RD
    Brott, TG
    Cady, WJ
    Caplan, LR
    Coggins, S
    Cramer, S
    Cyrus, P
    Dayno, J
    Easton, JD
    Elliott, PJ
    Finklestein, SP
    Furlan, AJ
    Gamzu, E
    Glasky, MS
    Gordon, K
    Gorelick, PB
    Greenwood, DT
    Grotta, JC
    Gunn, K
    Hachinski, V
    Hacke, W
    Hall, ED
    Hsu, CY
    Humphreys, DM
    Ishikawa, H
    Jacobs, AJ
    Kaste, M
    Koroshetz, WJ
    Krams, M
    Lauritano, AA
    Leclerc, J
    Lees, KR
    Lesko, L
    Levine, SR
    Levy, DE
    Li, FH
    Lyden, PD
    Masayasu, H
    [J]. STROKE, 2001, 32 (07) : 1598 - 1606
  • [2] Cytokines and acute neurodegeneration
    Allan, SM
    Rothwell, NJ
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (10) : 734 - 744
  • [3] Immune function of microglia
    Aloisi, F
    [J]. GLIA, 2001, 36 (02) : 165 - 179
  • [4] Phospholipases C and A2 control lysosome-mediated IL-1β secretion:: Implications for inflammatory processes
    Andrei, C
    Margiocco, P
    Poggi, A
    Lotti, LV
    Torrisi, MR
    Rubartelli, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9745 - 9750
  • [5] CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown
    Anthony, D
    Dempster, R
    Fearn, S
    Clements, J
    Wells, G
    Perry, VH
    Walker, K
    [J]. CURRENT BIOLOGY, 1998, 8 (16) : 923 - 926
  • [6] Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity
    Avital, A
    Goshen, I
    Kamsler, A
    Segal, M
    Iverfeldt, K
    Richter-Levin, G
    Yirmiya, R
    [J]. HIPPOCAMPUS, 2003, 13 (07) : 826 - 834
  • [7] FEVER IN ACUTE STROKE WORSENS PROGNOSIS - A PROSPECTIVE-STUDY
    AZZIMONDI, G
    BASSEIN, L
    NONINO, F
    FIORANI, L
    VIGNATELLI, L
    RE, G
    DALESSANDRO, R
    [J]. STROKE, 1995, 26 (11) : 2040 - 2043
  • [8] Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury
    Basu, A
    Lazovic, J
    Krady, JK
    Mauger, DT
    Rothstein, RP
    Smith, MB
    Levison, SW
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (01) : 17 - 29
  • [9] Interleukin-1: A master regulator of neuroinflammation
    Basu, A
    Krady, JK
    Levison, SW
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (02) : 151 - 156
  • [10] INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE
    BEAMER, NB
    COULL, BM
    CLARK, WM
    HAZEL, JS
    SILBERGER, JR
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (06) : 800 - 805